Loading…

Expression patterns of β-catenin in in situ and invasive breast cancer

Backgroundβ-Catenin plays a central role in the E-cadherin/catenin cell–cell adhesion complex and is possibly involved in cellular signalling pathways. In this study, we evaluated the expression patterns of this molecule in in situ and invasive breast cancer. Methods The expression of β-catenin was...

Full description

Saved in:
Bibliographic Details
Published in:European journal of surgical oncology 2001-02, Vol.27 (1), p.31-36
Main Authors: Karayiannakis, A.J., Nakopoulou, L., Gakiopoulou, H., Keramopoulos, A., Davaris, P.S., Pignatelli, M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c340t-2fc836276ecd3c61a4c3762074450b135d41e0d79908084fc9386bac4dfcbf333
cites cdi_FETCH-LOGICAL-c340t-2fc836276ecd3c61a4c3762074450b135d41e0d79908084fc9386bac4dfcbf333
container_end_page 36
container_issue 1
container_start_page 31
container_title European journal of surgical oncology
container_volume 27
creator Karayiannakis, A.J.
Nakopoulou, L.
Gakiopoulou, H.
Keramopoulos, A.
Davaris, P.S.
Pignatelli, M.
description Backgroundβ-Catenin plays a central role in the E-cadherin/catenin cell–cell adhesion complex and is possibly involved in cellular signalling pathways. In this study, we evaluated the expression patterns of this molecule in in situ and invasive breast cancer. Methods The expression of β-catenin was evaluated in 121 breast cancer specimens by immunohistochemistry. Its relationship to clinicopathological features was also investigated.Results Altered β-catenin expression was found in 68% of tumours. Lobular carcinomas showed abnormal β-catenin expression more frequently (77%) than ductal carcinomas (64%) with 46% of lobular cases showing complete absence of β-catenin immunoreactivity. Cytoplasmic β-catenin localization was seen only in ductal carcinomas. Aberrant β-catenin expression was observed in 54% of ductal carcinomas in situ with highly concordant β-catenin expression patterns in the nearby in situ and invasive components. Conclusions Quantitative and qualitative changes in β-catenin expression occur in a considerable proportion of in situ and invasive ductal carcinomas and are more prominent in invasive lobular carcinomas.
doi_str_mv 10.1053/ejso.1999.1017
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70689604</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S074879839991017X</els_id><sourcerecordid>70689604</sourcerecordid><originalsourceid>FETCH-LOGICAL-c340t-2fc836276ecd3c61a4c3762074450b135d41e0d79908084fc9386bac4dfcbf333</originalsourceid><addsrcrecordid>eNp1kEFLwzAUx4Mobk6vHqUnb51JkzbJUcacwsCLnkOavELG1tYkHfq1_CB-JlM68CQEXkJ-7897P4RuCV4SXNIH2IVuSaSU6Un4GZqTkhZ5QUp-juaYM5FzKegMXYWwwxhLyuUlmhFS0PQn52iz_uw9hOC6Nut1jODbkHVN9vOdGx2hdW02neDikOnWpvtRB3eErPagQ8yMbg34a3TR6H2Am1NdoPen9dvqOd--bl5Wj9vcUIZjXjRG0KrgFRhLTUU0M5RXRRqUlbgmtLSMALZcSiywYI2RVFS1Nsw2pm4opQt0P-X2vvsYIER1cMHAfq9b6IagOK6ErDBL4HICje9C8NCo3ruD9l-KYDWqU6M6NapTo7rUcHdKHuoD2D_85CoBYgIg7Xd04FUwDtLy1nkwUdnO_Zf9Cz2kfcw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70689604</pqid></control><display><type>article</type><title>Expression patterns of β-catenin in in situ and invasive breast cancer</title><source>Elsevier:Jisc Collections:Elsevier Read and Publish Agreement 2022-2024:Freedom Collection (Reading list)</source><creator>Karayiannakis, A.J. ; Nakopoulou, L. ; Gakiopoulou, H. ; Keramopoulos, A. ; Davaris, P.S. ; Pignatelli, M.</creator><creatorcontrib>Karayiannakis, A.J. ; Nakopoulou, L. ; Gakiopoulou, H. ; Keramopoulos, A. ; Davaris, P.S. ; Pignatelli, M.</creatorcontrib><description>Backgroundβ-Catenin plays a central role in the E-cadherin/catenin cell–cell adhesion complex and is possibly involved in cellular signalling pathways. In this study, we evaluated the expression patterns of this molecule in in situ and invasive breast cancer. Methods The expression of β-catenin was evaluated in 121 breast cancer specimens by immunohistochemistry. Its relationship to clinicopathological features was also investigated.Results Altered β-catenin expression was found in 68% of tumours. Lobular carcinomas showed abnormal β-catenin expression more frequently (77%) than ductal carcinomas (64%) with 46% of lobular cases showing complete absence of β-catenin immunoreactivity. Cytoplasmic β-catenin localization was seen only in ductal carcinomas. Aberrant β-catenin expression was observed in 54% of ductal carcinomas in situ with highly concordant β-catenin expression patterns in the nearby in situ and invasive components. Conclusions Quantitative and qualitative changes in β-catenin expression occur in a considerable proportion of in situ and invasive ductal carcinomas and are more prominent in invasive lobular carcinomas.</description><identifier>ISSN: 0748-7983</identifier><identifier>EISSN: 1532-2157</identifier><identifier>DOI: 10.1053/ejso.1999.1017</identifier><identifier>PMID: 11237489</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adult ; Aged ; Aged, 80 and over ; beta Catenin ; breast cancer ; Breast Neoplasms - chemistry ; Breast Neoplasms - pathology ; Cadherins - analysis ; Carcinoma, Intraductal, Noninfiltrating - chemistry ; Carcinoma, Intraductal, Noninfiltrating - pathology ; Carcinoma, Lobular - chemistry ; Carcinoma, Lobular - pathology ; cell adhesion ; Cytoplasm - chemistry ; Cytoskeletal Proteins - analysis ; ductal carcinoma in situ ; Female ; Humans ; Immunohistochemistry ; Middle Aged ; Neoplasm Invasiveness ; Trans-Activators ; β-catenin</subject><ispartof>European journal of surgical oncology, 2001-02, Vol.27 (1), p.31-36</ispartof><rights>2001 Harcourt Publishers Ltd</rights><rights>Copyright Harcourt Publishers Limited.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c340t-2fc836276ecd3c61a4c3762074450b135d41e0d79908084fc9386bac4dfcbf333</citedby><cites>FETCH-LOGICAL-c340t-2fc836276ecd3c61a4c3762074450b135d41e0d79908084fc9386bac4dfcbf333</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11237489$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Karayiannakis, A.J.</creatorcontrib><creatorcontrib>Nakopoulou, L.</creatorcontrib><creatorcontrib>Gakiopoulou, H.</creatorcontrib><creatorcontrib>Keramopoulos, A.</creatorcontrib><creatorcontrib>Davaris, P.S.</creatorcontrib><creatorcontrib>Pignatelli, M.</creatorcontrib><title>Expression patterns of β-catenin in in situ and invasive breast cancer</title><title>European journal of surgical oncology</title><addtitle>Eur J Surg Oncol</addtitle><description>Backgroundβ-Catenin plays a central role in the E-cadherin/catenin cell–cell adhesion complex and is possibly involved in cellular signalling pathways. In this study, we evaluated the expression patterns of this molecule in in situ and invasive breast cancer. Methods The expression of β-catenin was evaluated in 121 breast cancer specimens by immunohistochemistry. Its relationship to clinicopathological features was also investigated.Results Altered β-catenin expression was found in 68% of tumours. Lobular carcinomas showed abnormal β-catenin expression more frequently (77%) than ductal carcinomas (64%) with 46% of lobular cases showing complete absence of β-catenin immunoreactivity. Cytoplasmic β-catenin localization was seen only in ductal carcinomas. Aberrant β-catenin expression was observed in 54% of ductal carcinomas in situ with highly concordant β-catenin expression patterns in the nearby in situ and invasive components. Conclusions Quantitative and qualitative changes in β-catenin expression occur in a considerable proportion of in situ and invasive ductal carcinomas and are more prominent in invasive lobular carcinomas.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>beta Catenin</subject><subject>breast cancer</subject><subject>Breast Neoplasms - chemistry</subject><subject>Breast Neoplasms - pathology</subject><subject>Cadherins - analysis</subject><subject>Carcinoma, Intraductal, Noninfiltrating - chemistry</subject><subject>Carcinoma, Intraductal, Noninfiltrating - pathology</subject><subject>Carcinoma, Lobular - chemistry</subject><subject>Carcinoma, Lobular - pathology</subject><subject>cell adhesion</subject><subject>Cytoplasm - chemistry</subject><subject>Cytoskeletal Proteins - analysis</subject><subject>ductal carcinoma in situ</subject><subject>Female</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Middle Aged</subject><subject>Neoplasm Invasiveness</subject><subject>Trans-Activators</subject><subject>β-catenin</subject><issn>0748-7983</issn><issn>1532-2157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNp1kEFLwzAUx4Mobk6vHqUnb51JkzbJUcacwsCLnkOavELG1tYkHfq1_CB-JlM68CQEXkJ-7897P4RuCV4SXNIH2IVuSaSU6Un4GZqTkhZ5QUp-juaYM5FzKegMXYWwwxhLyuUlmhFS0PQn52iz_uw9hOC6Nut1jODbkHVN9vOdGx2hdW02neDikOnWpvtRB3eErPagQ8yMbg34a3TR6H2Am1NdoPen9dvqOd--bl5Wj9vcUIZjXjRG0KrgFRhLTUU0M5RXRRqUlbgmtLSMALZcSiywYI2RVFS1Nsw2pm4opQt0P-X2vvsYIER1cMHAfq9b6IagOK6ErDBL4HICje9C8NCo3ruD9l-KYDWqU6M6NapTo7rUcHdKHuoD2D_85CoBYgIg7Xd04FUwDtLy1nkwUdnO_Zf9Cz2kfcw</recordid><startdate>20010201</startdate><enddate>20010201</enddate><creator>Karayiannakis, A.J.</creator><creator>Nakopoulou, L.</creator><creator>Gakiopoulou, H.</creator><creator>Keramopoulos, A.</creator><creator>Davaris, P.S.</creator><creator>Pignatelli, M.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010201</creationdate><title>Expression patterns of β-catenin in in situ and invasive breast cancer</title><author>Karayiannakis, A.J. ; Nakopoulou, L. ; Gakiopoulou, H. ; Keramopoulos, A. ; Davaris, P.S. ; Pignatelli, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c340t-2fc836276ecd3c61a4c3762074450b135d41e0d79908084fc9386bac4dfcbf333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>beta Catenin</topic><topic>breast cancer</topic><topic>Breast Neoplasms - chemistry</topic><topic>Breast Neoplasms - pathology</topic><topic>Cadherins - analysis</topic><topic>Carcinoma, Intraductal, Noninfiltrating - chemistry</topic><topic>Carcinoma, Intraductal, Noninfiltrating - pathology</topic><topic>Carcinoma, Lobular - chemistry</topic><topic>Carcinoma, Lobular - pathology</topic><topic>cell adhesion</topic><topic>Cytoplasm - chemistry</topic><topic>Cytoskeletal Proteins - analysis</topic><topic>ductal carcinoma in situ</topic><topic>Female</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Middle Aged</topic><topic>Neoplasm Invasiveness</topic><topic>Trans-Activators</topic><topic>β-catenin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Karayiannakis, A.J.</creatorcontrib><creatorcontrib>Nakopoulou, L.</creatorcontrib><creatorcontrib>Gakiopoulou, H.</creatorcontrib><creatorcontrib>Keramopoulos, A.</creatorcontrib><creatorcontrib>Davaris, P.S.</creatorcontrib><creatorcontrib>Pignatelli, M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Karayiannakis, A.J.</au><au>Nakopoulou, L.</au><au>Gakiopoulou, H.</au><au>Keramopoulos, A.</au><au>Davaris, P.S.</au><au>Pignatelli, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression patterns of β-catenin in in situ and invasive breast cancer</atitle><jtitle>European journal of surgical oncology</jtitle><addtitle>Eur J Surg Oncol</addtitle><date>2001-02-01</date><risdate>2001</risdate><volume>27</volume><issue>1</issue><spage>31</spage><epage>36</epage><pages>31-36</pages><issn>0748-7983</issn><eissn>1532-2157</eissn><abstract>Backgroundβ-Catenin plays a central role in the E-cadherin/catenin cell–cell adhesion complex and is possibly involved in cellular signalling pathways. In this study, we evaluated the expression patterns of this molecule in in situ and invasive breast cancer. Methods The expression of β-catenin was evaluated in 121 breast cancer specimens by immunohistochemistry. Its relationship to clinicopathological features was also investigated.Results Altered β-catenin expression was found in 68% of tumours. Lobular carcinomas showed abnormal β-catenin expression more frequently (77%) than ductal carcinomas (64%) with 46% of lobular cases showing complete absence of β-catenin immunoreactivity. Cytoplasmic β-catenin localization was seen only in ductal carcinomas. Aberrant β-catenin expression was observed in 54% of ductal carcinomas in situ with highly concordant β-catenin expression patterns in the nearby in situ and invasive components. Conclusions Quantitative and qualitative changes in β-catenin expression occur in a considerable proportion of in situ and invasive ductal carcinomas and are more prominent in invasive lobular carcinomas.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>11237489</pmid><doi>10.1053/ejso.1999.1017</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0748-7983
ispartof European journal of surgical oncology, 2001-02, Vol.27 (1), p.31-36
issn 0748-7983
1532-2157
language eng
recordid cdi_proquest_miscellaneous_70689604
source Elsevier:Jisc Collections:Elsevier Read and Publish Agreement 2022-2024:Freedom Collection (Reading list)
subjects Adult
Aged
Aged, 80 and over
beta Catenin
breast cancer
Breast Neoplasms - chemistry
Breast Neoplasms - pathology
Cadherins - analysis
Carcinoma, Intraductal, Noninfiltrating - chemistry
Carcinoma, Intraductal, Noninfiltrating - pathology
Carcinoma, Lobular - chemistry
Carcinoma, Lobular - pathology
cell adhesion
Cytoplasm - chemistry
Cytoskeletal Proteins - analysis
ductal carcinoma in situ
Female
Humans
Immunohistochemistry
Middle Aged
Neoplasm Invasiveness
Trans-Activators
β-catenin
title Expression patterns of β-catenin in in situ and invasive breast cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T23%3A21%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20patterns%20of%20%CE%B2-catenin%20in%20in%20situ%20and%20invasive%20breast%20cancer&rft.jtitle=European%20journal%20of%20surgical%20oncology&rft.au=Karayiannakis,%20A.J.&rft.date=2001-02-01&rft.volume=27&rft.issue=1&rft.spage=31&rft.epage=36&rft.pages=31-36&rft.issn=0748-7983&rft.eissn=1532-2157&rft_id=info:doi/10.1053/ejso.1999.1017&rft_dat=%3Cproquest_cross%3E70689604%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c340t-2fc836276ecd3c61a4c3762074450b135d41e0d79908084fc9386bac4dfcbf333%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70689604&rft_id=info:pmid/11237489&rfr_iscdi=true